Results 241 to 250 of about 50,213 (312)

Influence of material structure properties on sliding contact performance of CGRP composite [PDF]

, 2008
B.F. Yousif, N.S.M. El-Tayeb, Talal Yusaf   +2 more
openalex  

Targeting molecular pathways in neuropathic cancer pain: from mechanisms to novel therapeutics. [PDF]

iScience
Xu X, Lei Y, Lu C, Liu M, Meng Y, Zeng C, Gao Y, Zhou H, Xi Y.   +8 more
europepmc   +1 more source

CGRP: Clinical Commentary [PDF]

Headache: The Journal of Head and Face Pain, 2008
openaire   +2 more sources

Enteric glia, neuropeptides, and Parkinson's: impacts of calcitonin gene-related peptide on gut alpha synuclein. [PDF]

Am J Physiol Gastrointest Liver Physiol
Templeton HN, Lanser TB, Tobet SA, Schwerdtfeger LA.   +3 more
europepmc   +1 more source

Amylin/CGRP

, 2013
openaire   +2 more sources

Real-World Experience with Anti-CGRP Pathway Monoclonal Antibodies in a Large United States Healthcare Plan: Results of the Migraine Signature Study. [PDF]

Neurol Ther
Buse DC, Lipton RB, Urman R, Vaidya SJ, Robinson SC, Jacobson AS, Scott AB, Bensink ME, Pressman AR.   +8 more
europepmc   +1 more source

Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients [PDF]

Vittorio Schweiger, Paola Bellamoli, Francesco Taus, Leonardo Gottin, Alvise Martini, Marta Nizzero, Eleonora Bonora, Giovanna Del Balzo, Katia Donadello, Erica Secchettin, Gabriele Finco, Daniele De Santis, Enrico Polati   +12 more
openalex   +1 more source

Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy". [PDF]

Eur J Neurol
Rifino N, Aamodt AH, Wiedmann M, Kramer M, Becker J, Guey S, Acerbi F, Herve D, Bersano A.   +8 more
europepmc   +1 more source